BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tikkanen A, Pierrot E, Deng F, Sánchez VB, Hagström M, Koenderink JB, Kidron H. Food Additives as Inhibitors of Intestinal Drug Transporter OATP2B1. Mol Pharm 2020;17:3748-58. [PMID: 32845645 DOI: 10.1021/acs.molpharmaceut.0c00507] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Häkkinen K, Kiander W, Kidron H, Lähteenvuo M, Urpa L, Lintunen J, Vellonen K, Auriola S, Holm M, Lahdensuo K, Kampman O, Isometsä E, Kieseppä T, Lönnqvist J, Suvisaari J, Hietala J, Tiihonen J, Palotie A, Ahola-olli AV, Niemi M, the SUPER-Finland researchers listed in the Acknowledgements. Functional characterization of six SLCO1B1 (OATP1B1) variants observed in Finnish individuals with a psychotic disorder.. [DOI: 10.1101/2022.08.10.22278615] [Reference Citation Analysis]
2 Huttunen J, Adla SK, Markowicz-Piasecka M, Huttunen KM. Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs). Pharmaceutics 2022;14:1234. [PMID: 35745806 DOI: 10.3390/pharmaceutics14061234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Martínez MF, López Pérez MC, Labrada FP. Qualitative Consumption of Processed Foods with Allura Red Additive in Mexican Primary School Children. Curr Res Nutr Food Sci 2022;10:384-392. [DOI: 10.12944/crnfsj.10.1.32] [Reference Citation Analysis]
4 Kiander W, Vellonen KS, Malinen MM, Gynther M, Hagström M, Bhattacharya M, Auriola S, Koenderink JB, Kidron H. The Effect of Single Nucleotide Variations in the Transmembrane Domain of OATP1B1 on in vitro Functionality. Pharm Res 2021;38:1663-75. [PMID: 34647232 DOI: 10.1007/s11095-021-03107-8] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]